Tag: symptomatic coronavirus
Photo: pib.gov
India’s COVID-19 Vaccination Coverage exceeds 38.50 Cr
India’s cumulative COVID Vaccination Coverage exceeded 38.50 crore (38,50,19,469), as per the 7 pm provisional report today. The new phase of universalization of COVID-19 vaccination commenced from 21st June. More than 34.10 lakh (34,10,974) Vaccine Doses have been administered today, as per the 7 pm… Read More
Photo: Swarajyamag
Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
The final phase 3 analysis of Covaxin, the Covid-19 jab developed by Bharat Biotech, has shown the efficacy of 78 per cent in preventing symptomatic coronavirus caused disease, a report said. . Read more at: https://swarajyamag.com/news-brief/bharat-biotechs-covaxin-shows-78-percent-efficacy-in-phase-3-analysis . Read More
